IC
Imperative Care
United States · Healthtech
Develops treatments for patients suffering from thromboembolic disease
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Growth | $100M | Ally Bridge Group — Role not disclosedBain Capital Life Sciences — Role not disclosedBrown Advisory — Role not disclosedCatalio Capital Management — Role not disclosedElevage Medical Technologies — Role not disclosedLongaeva Partners — Role not disclosedPerceptive Advisors — Role not disclosed |